au.\*:("YUN HEE HAN")
Results 1 to 1 of 1
Selection :
Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doubletsDAE HO LEE; KIM, Sang-We; SUH, Cheolwon et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 1, pp 35-39, issn 0344-5704, 5 p.Article